Annual report pursuant to Section 13 and 15(d)

Consolidated Statement of Stockholders' Equity

v3.20.1
Consolidated Statement of Stockholders' Equity - USD ($)
Series A Convertible Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Total
Balance at Dec. 31, 2017 $ 3,500,000 $ 5,802 $ 20,004,654 $ (22,515,415) $ 995,041
Balance, shares at Dec. 31, 2017 350,000 58,025,814      
Sale of common stock $ 900 4,499,100 4,500,000
Sale of common stock, shares 9,000,000      
Costs incurred in connection with the sale of common stock units (24,702) (24,702)
Exercise of common stock options $ 2 2,998 $ 3,000
Exercise of common stock options, shares 20,000     20,000
Stock-based compensation expense, including $711,738 for extension of stock options to related party 785,612 $ 785,612
Net loss (2,133,128) (2,133,128)
Balance at Dec. 31, 2018 $ 3,500,000 $ 6,704 25,267,662 (24,648,543) 4,125,823
Balance, shares at Dec. 31, 2018 350,000 67,045,814      
Stock-based compensation expense 748,655 748,655
Net loss (2,440,343) (2,440,343)
Balance at Dec. 31, 2019 $ 3,500,000 $ 6,704 $ 26,016,317 $ (27,088,886) $ 2,434,135
Balance, shares at Dec. 31, 2019 350,000 67,045,814